Post-Brexit and with escalating costs of patents and no Unified Patents Court, we ask might copyright protection offer a more cost effective protection to recombinant derived small molecule pharmaceuticals?
Mark Engelman, Michael Kock and Martin Gouldstone will cover the following topics:
- IP Protection for DNA Sequences: Patents vs. Copyright – Challenges, Limitations, Opportunities
- Legal developments in copyright and gene sequences
- The science of gene sequences